Diagnosis of cancer is one of the biggest challenges in modern medicine. Early detection saves lives and increases chance of survival. Diagnosis in developing countries even more difficult as basic lab infrastructure may be unavailable. On average, 70% of people in developing countries do not get diagnosed until a late stage, when treatment is no longer effective. This statistic drives the need for simple and accurate diagnostic technology. Research in early cancer diagnosis has focused on biomarkers.